These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 30325267)
21. Proceedings of the 2nd International Summit Meeting on Immunological Correlates of Protection from HIV Infection and Disease. Oxford, United Kingdom, 17-20 April 1998. Immunol Lett; 1999 Mar; 66(1-3):1-228. PubMed ID: 10357622 [No Abstract] [Full Text] [Related]
22. Editorial commentary: monitoring early warning indicators for HIV drug resistance in South Africa: challenges and opportunities. Rossouw TM Clin Infect Dis; 2014 Jun; 58(11):1615-7. PubMed ID: 24585563 [No Abstract] [Full Text] [Related]
24. HIV Drug Resistance - An Emerging Threat to Epidemic Control. Beyrer C; Pozniak A N Engl J Med; 2017 Oct; 377(17):1605-1607. PubMed ID: 29069566 [No Abstract] [Full Text] [Related]
26. Can immune systems be trained to fight HIV? Balter M Science; 1999 Nov; 286(5444):1470-11. PubMed ID: 10610544 [No Abstract] [Full Text] [Related]
27. Researchers announce first correlates of protection for HIV vaccine. Roehr B BMJ; 2011 Sep; 343():d5880. PubMed ID: 21920885 [No Abstract] [Full Text] [Related]
29. Antiretroviral therapy: a primer for dermatologists. Kim HN; Harrington RD Dermatol Clin; 2006 Oct; 24(4):537-47, vii. PubMed ID: 17010782 [TBL] [Abstract][Full Text] [Related]
30. RV144: old vs. new. Weiner DB Hum Vaccin; 2010 Feb; 6(2):159-61. PubMed ID: 20431335 [No Abstract] [Full Text] [Related]
31. Individualized antiretroviral therapeutic approaches: less can be more. Katlama C; Ghosn J; Murphy RL AIDS; 2017 May; 31(8):1065-1071. PubMed ID: 28358730 [No Abstract] [Full Text] [Related]
32. Functional cure of HIV: the scale of the challenge. Davenport MP; Khoury DS; Cromer D; Lewin SR; Kelleher AD; Kent SJ Nat Rev Immunol; 2019 Jan; 19(1):45-54. PubMed ID: 30410126 [TBL] [Abstract][Full Text] [Related]
33. Precision medicine for HIV: where are we? Cusato J; Allegra S; Nicolò A; Calcagno A; D'Avolio A Pharmacogenomics; 2018 Jan; 19(2):145-165. PubMed ID: 29202676 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic optimization of antiretroviral therapy in children and adolescents. Neely MN; Rakhmanina NY Clin Pharmacokinet; 2011 Mar; 50(3):143-89. PubMed ID: 21294595 [TBL] [Abstract][Full Text] [Related]
35. [Mutations resulting in resistence of antiretroviral drugs in HIV-infected patients]. Cabrera C; Clotet B Med Clin (Barc); 2005 Apr; 124(16):618-9. PubMed ID: 15871779 [No Abstract] [Full Text] [Related]
36. The RV144 Thai HIV vaccine trial. Plotkin SA Hum Vaccin; 2010 Feb; 6(2):159. PubMed ID: 20431337 [No Abstract] [Full Text] [Related]
38. Challenges and opportunities for development of an AIDS vaccine. Nabel GJ Nature; 2001 Apr; 410(6831):1002-7. PubMed ID: 11309631 [TBL] [Abstract][Full Text] [Related]
39. Thirty years of HIV and AIDS: future challenges and opportunities. Dieffenbach CW; Fauci AS Ann Intern Med; 2011 Jun; 154(11):766-71. PubMed ID: 21628350 [TBL] [Abstract][Full Text] [Related]